pro-MCH Inhibitors
Pro-MCH inhibitors constitute a diverse class of chemical compounds designed to modulate the expression and signaling of the precursor protein melanin-concentrating hormone (pro-MCH). The regulatory network governing pro-MCH involves intricate interactions with various signaling pathways and receptors. One approach to inhibiting pro-MCH involves targeting orexin receptors, which play a crucial role in the modulation of MCH signaling. Compounds such as SB-334867, TCS-OX2-29, GSK1059865, and Almorexant selectively block orexin receptors, indirectly influencing pro-MCH levels and providing researchers with a toolkit for investigating the specific roles of orexin signaling in pro-MCH expression.
Another avenue for pro-MCH inhibition involves the use of MCH1R antagonists, such as SNAP-7941, A-71623, and GW803430, which specifically target the melanin-concentrating hormone receptor 1 (MCH1R). By blocking MCH1R, these compounds can modulate pro-MCH signaling and expression, offering researchers a focused approach to explore the direct impact of receptor inhibition on pro-MCH. Additionally, histamine H1 receptor antagonists, corticotropin-releasing factor (CRF) antagonists, GABA-B receptor antagonists, 5-HT2C receptor antagonists, cannabinoid receptor antagonists, neuropeptide Y (NPY) receptor antagonists, and opioid receptor antagonists present diverse strategies for indirectly influencing pro-MCH levels by targeting interconnected signaling pathways. The use of these inhibitors provides researchers with a powerful means to decipher the complex regulatory mechanisms governing pro-MCH-mediated cellular processes. Investigating the interplay between orexin signaling, receptor-specific inhibition, and the modulation of pro-MCH expression offers valuable insights into the intricate web of pathways influencing pro-MCH-related cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB-334867 | 792173-99-0 | sc-507323 | 10 mg | $207.00 | ||
SB-334867 is a selective orexin receptor 1 antagonist. By blocking orexin signaling, this compound may indirectly modulate pro-MCH levels. Orexin receptors play a role in regulating the expression of MCH, the precursor of pro-MCH, and SB-334867 offers a potential avenue to explore the intricate regulatory network governing pro-MCH and its related pathways. | ||||||
TCS OX2 29 | 372523-75-6 | sc-204329 sc-204329A | 10 mg 50 mg | $185.00 $781.00 | ||
TCS-OX2-29 is a selective orexin receptor 2 antagonist. Similar to SB-334867, it can indirectly influence pro-MCH levels by blocking orexin signaling. The selective targeting of orexin receptors provides researchers with a tool to investigate the specific roles of orexin signaling in pro-MCH expression and the modulation of pro-MCH-related cellular processes. | ||||||
Almorexant | 871224-64-5 | sc-507322 | 10 mg | $330.00 | ||
Almorexant is a dual orexin receptor antagonist that, like GSK1059865, targets both orexin receptor subtypes. Through its action on orexin receptors, Almorexant may indirectly modulate pro-MCH levels. The compound offers researchers a comprehensive approach to investigate the regulatory roles of orexin signaling in pro-MCH expression and the cellular processes associated with pro-MCH. | ||||||
Antalarmin hydrochloride | 220953-69-5 | sc-203820 sc-203820A | 10 mg 50 mg | $186.00 $640.00 | 1 | |
Antalarmin is a corticotropin-releasing factor (CRF) antagonist that can potentially influence pro-MCH expression. The CRF system interacts with MCH signaling, and CRF antagonists like antalarmin may modulate pro-MCH levels. Researchers can use these antagonists to delve into the regulatory crosstalk between CRF signaling and pro-MCH, providing insights into the complex network governing pro-MCH-related cellular processes. | ||||||
SB 242084 hydrochloride | 1049747-87-6 | sc-351848 sc-351848A | 1 mg 5 mg | $100.00 $225.00 | ||
SB-242,084 is a 5-HT2C receptor antagonist that can potentially modulate pro-MCH levels. By blocking 5-HT2C receptors, this compound may affect serotonin signaling, which is known to interact with MCH. Researchers can utilize 5-HT2C receptor antagonists like SB-242,084 to explore the specific roles of serotonin in the regulation of pro-MCH expression and its impact on pro-MCH-related cellular processes. | ||||||
Rimonabant | 168273-06-1 | sc-205491 sc-205491A | 5 mg 10 mg | $73.00 $163.00 | 15 | |
Rimonabant (SR141716A) is a cannabinoid receptor antagonist that can potentially influence pro-MCH expression. By blocking cannabinoid receptors, this compound may affect endocannabinoid signaling, which interacts with MCH signaling. Researchers can use cannabinoid receptor antagonists like SR141716A to probe the regulatory crosstalk between endocannabinoid signaling and pro-MCH, providing insights into pro-MCH-related pathways. | ||||||
Naloxone | 465-65-6 | sc-477809 | 200 mg | $306.00 | 5 | |
Naloxone is an opioid receptor antagonist that can potentially influence pro-MCH expression. Opioid receptors interact with MCH signaling, and by blocking these receptors, naloxone may modulate pro-MCH levels. Researchers can use opioid receptor antagonists like naloxone to explore the regulatory crosstalk between opioid signaling and pro-MCH, providing valuable insights into the intricate network governing pro-MCH-related cellular processes. | ||||||